Viewing Study NCT00002832

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-04-08 @ 11:31 AM
Study NCT ID: NCT00002832
Status: COMPLETED
Last Update Posted: 2012-07-30
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Decitabine View
None Dacogen View
None Filgrastim View
None G-CSF View
None Neupogen View
None Cyclosporine View
None Sandimmune View
None CYA View
None Cyclosporin A View
None Peripheral blood stem cells View
None PBSC View
None Allogeneic bone marrow transplantation View
None recurrent childhood acute lymphoblastic leukemia View
None recurrent childhood acute myeloid leukemia View
None recurrent adult acute myeloid leukemia View
None recurrent adult acute lymphoblastic leukemia View
None accelerated phase chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None previously treated myelodysplastic syndromes View
None childhood myelodysplastic syndromes View